{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:49:55Z","timestamp":1792673395428,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI23\/00449"],"award-info":[{"award-number":["PI23\/00449"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI20\/00075"],"award-info":[{"award-number":["PI20\/00075"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI17\/00495"],"award-info":[{"award-number":["PI17\/00495"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI24\/01607"],"award-info":[{"award-number":["PI24\/01607"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["FI21\/00171"],"award-info":[{"award-number":["FI21\/00171"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["FORT23\/00021"],"award-info":[{"award-number":["FORT23\/00021"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031670","name":"Sociedad Espa\u00f1ola de Trombosis y Hemostasia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031670","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jmoldx.2025.08.010","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T05:21:14Z","timestamp":1758950474000},"page":"1189-1201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of the Fragmentation and Integrity of Urine Cell-Free DNA as a Diagnostic and Staging Biomarker for Bladder Cancer"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0894-2946","authenticated-orcid":false,"given":"Raquel","family":"Herranz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Oto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8457-6984","authenticated-orcid":false,"given":"Emma","family":"Plana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3840-919X","authenticated-orcid":false,"given":"Javier","family":"P\u00e9rez-Ardav\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8768-331X","authenticated-orcid":false,"given":"Patricia","family":"Verger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Mart\u00ednez-Sarmiento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar D.","family":"Vera-Donoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9637-5998","authenticated-orcid":false,"given":"Pilar","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2025.08.010_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib2","article-title":"Bladder cancer","volume":"3","author":"Sanli","year":"2017","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib3","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.21037\/tcr-20-1990","article-title":"Review of non-invasive urinary biomarkers in bladder cancer","volume":"9","author":"Lee","year":"2020","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib4","first-page":"1659","article-title":"DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells","volume":"61","author":"Jahr","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1258\/000456303763046030","article-title":"Clinical Sciences Reviews Committee of the Association of Clinical Biochemists. Cell-free nucleic acids in plasma, serum and urine: a new tool in molecular diagnosis","volume":"40","author":"Chan","year":"2003","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients","volume":"11","author":"Schwarzenbach","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib7","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.21037\/tau.2017.09.16","article-title":"The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer","volume":"6","author":"Riethdorf","year":"2017","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: towards implementation of circulating tumour DNA","volume":"17","author":"Wan","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat4921","article-title":"Enhanced detection of circulating tumor DNA by fragment size analysis","volume":"10","author":"Mouliere","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2019-000572","article-title":"Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients","volume":"4","author":"Crisafulli","year":"2019","journal-title":"ESMO Open"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejca.2019.12.023","article-title":"Induction of apoptosis increases sensitivity to detect cancer mutations in plasma","volume":"127","author":"Marques","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/cas.14679","article-title":"Fragmentation of cell-free DNA is induced by upper-tract urothelial carcinoma-associated systemic inflammation","volume":"112","author":"Nakano","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/CBM-2012-0263","article-title":"Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients","volume":"11","author":"Agostini","year":"2012","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jnci.2016.08.003","article-title":"Quantitative analysis of plasma cell-free DNA and its DNA integrity in patients with metastatic prostate cancer using ALU sequence","volume":"28","author":"Fawzy","year":"2016","journal-title":"J Egypt Natl Canc Inst"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","article-title":"Liquid biopsies: genotyping circulating tumor DNA","volume":"32","author":"Diaz","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2017.10.029","article-title":"Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients","volume":"88","author":"Valpione","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13061448","article-title":"Circulating cell-free DNA in liquid biopsies as potential biomarker for bladder cancer: a review","volume":"13","author":"Herranz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib18","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/diagnostics11020306","article-title":"Urinary cell-free DNA in bladder cancer detection","volume":"11","author":"Tse","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejca.2021.09.042","article-title":"Circulating tumour DNA sequencing to determine therapeutic response and identify tumour heterogeneity in patients with paediatric solid tumours","volume":"162","author":"Stankunaite","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.canlet.2008.01.038","article-title":"Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: a prognostic entity","volume":"264","author":"Ellinger","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib21","first-page":"3119","article-title":"Cell-free serum DNA in patients with bladder cancer: results of a prospective multicenter study","volume":"32","author":"Hauser","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13046-018-0688-4","article-title":"Serum DNA integrity index as a potential molecular biomarker in endometrial cancer","volume":"37","author":"Vizza","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib23","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1007\/s12010-018-2858-4","article-title":"Plasma ALU-247, ALU-115, and cfDNA integrity as diagnostic and prognostic biomarkers for breast cancer","volume":"187","author":"Hussein","year":"2019","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib24","first-page":"334","article-title":"Integrity and quantity evaluation of plasma cell-free DNA in triple negative breast cancer","volume":"11","author":"Salimi","year":"2019","journal-title":"Avicenna J Med Biotechnol"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib25","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.21037\/jgo-20-509","article-title":"Relationship between plasma cell-free DNA (cfDNA) and prognosis of TACE for primary hepatocellular carcinoma","volume":"11","author":"Ma","year":"2020","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib26","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.urolonc.2012.07.013","article-title":"Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data","volume":"31","author":"Casadio","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/clinchem\/hvaa325","article-title":"Jagged ends of urinary cell-free DNA: characterization and feasibility assessment in bladder cancer detection","volume":"67","author":"Zhou","year":"2021","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib28","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/clinchem\/hvae156","article-title":"Machine learning-based detection of bladder cancer by urine cfDNA fragmentation hotspots that capture cancer-associated molecular features","volume":"70","author":"Meng","year":"2024","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib29","series-title":"Histological Typing of Urinary Bladder Tumours","author":"Mostofi","year":"1973"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/106689690501300203","article-title":"The 2004 WHO classification of bladder tumors: a summary and commentary","volume":"13","author":"Montironi","year":"2005","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib31","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jmoldx.2023.08.006","article-title":"Impact of cell-debris and room-temperature storage on urine circulating tumor DNA from hepatocellular carcinoma","volume":"25","author":"Kim","year":"2023","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jmoldx.2024.12.008","article-title":"Optimization of pre-analytical handling to maintain DNA integrity in diagnostic papanicolaou tests","volume":"27","author":"Schumacher","year":"2025","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/172460080702200408","article-title":"Urinary cell-free DNA as a potential tumor marker for bladder cancer","volume":"22","author":"Chang","year":"2007","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/270457","article-title":"Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot study","volume":"2013","author":"Casadio","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/574120","article-title":"Urine cell-free DNA integrity analysis for early detection of prostate cancer patients","volume":"2015","author":"Salvi","year":"2015","journal-title":"Dis Markers"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib36","article-title":"Cell-free DNA integrity analysis in urine samples","volume":"119","author":"Casadio","year":"2017","journal-title":"J Vis Exp"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib37","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","article-title":"Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018","volume":"74","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214197","article-title":"Cell-free DNA fragmentomics: a promising biomarker for diagnosis, prognosis and prediction of response in breast cancer","volume":"23","author":"Gianni","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1525-1578(10)60497-7","article-title":"Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and May be useful in the detection of colorectal cancer","volume":"6","author":"Su","year":"2004","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib40","first-page":"1837","article-title":"DNA integrity as biomarker in pancreatic cyst fluid","volume":"6","author":"Utomo","year":"2016","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib41","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202217282","article-title":"Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencing","volume":"15","author":"van der Pol","year":"2023","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3537471","article-title":"Regulation of tumor progression by programmed necrosis","volume":"2018","author":"Lee","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib43","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1373\/clinchem.2018.301341","article-title":"Noninvasive detection of bladder cancer by shallow-depth genome-wide bisulfite sequencing of urinary cell-free DNA for methylation and copy number profiling","volume":"65","author":"Cheng","year":"2019","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib44","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41585-023-00761-y","article-title":"The androgen receptor in bladder cancer","volume":"20","author":"Chen","year":"2023","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib45","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12672-024-01173-z","article-title":"The roles of FGFR3 and c-MYC in urothelial bladder cancer","volume":"15","author":"Bogale","year":"2024","journal-title":"Discov Oncol"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40164-025-00649-0","article-title":"Validation of a microRNA profile in urine liquid biopsy with diagnostic and stratification value for bladder cancer classification, available through the open app BladdermiRaCan","volume":"14","author":"Oto","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.jmoldx.2025.08.010_bib47","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jmoldx.2024.01.008","article-title":"Extraction of cell-free DNA: evaluation of efficiency, quantity, and quality","volume":"26","author":"Terp","year":"2024","journal-title":"J Mol Diagn"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157825002223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157825002223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:57:05Z","timestamp":1773802625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157825002223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1525157825002223"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2025.08.010","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the Fragmentation and Integrity of Urine Cell-Free DNA as a Diagnostic and Staging Biomarker for Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2025.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}